ABZPF yields 3.45% · JNJ yields 2.13%● Live data
📍 ABZPF pulled ahead of the other in Year 1
Combined, ABZPF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ABZPF + JNJ for your $10,000?
Aboitiz Power Corporation, through its subsidiaries, engages in the power generation, distribution, and retail electricity businesses in the Philippines. It operates hydropower, geothermal, solar, coal, and oil power plants. The company sells its electricity through power supply contracts, ancillary service procurement agreements, and trading in the wholesale electricity spot market. It also distributes electricity to the industrial, residential, commercial, and other customers; and provides electricity-related services, such as installation of electrical equipment through nine distribution utilities that supply electricity to franchise areas covering 18 cities and municipalities and five economic zones in Luzon, Visayas, and Mindanao. In addition, the company is involved in the retail of electricity to various industries, including property development, meat processing, semiconductors, steel, and cement. As of February 28, 2022, it owned 5,332 megawatts of net sellable capacity. The company was incorporated in 1998 and is headquartered in Taguig City, the Philippines. Aboitiz Power Corporation is a subsidiary of Aboitiz Equity Ventures, Inc.
Full ABZPF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.